Company

Nuclivision BV

Nuclivision develops AI software for nuclear medicine and PET imaging workflows.

About

Nuclivision develops software for nuclear medicine, including Nuclarity, an AI product for PET imaging. Its tools are designed to support physicians from image acquisition through diagnosis and follow-up. Founded in 2022, the company is based in Ghent, Belgium. In April 2025, it raised EUR 5 million led by HERAN Partners, Imec.xpand, and LUMO Labs BV.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in